GLIPAZIN M 10

Dapagliflozin 10mg + Metformin 500mg

DAPAGLIFLOZIN

Selective sodium-glucose co-transporter type 2 inhibitor (iSGLT2), blocks glucose re-absorption in the proximal tubule of the kidney
Increases urinary glucose excretion and reduces blood glucose levels
METFORMIN

A biguanide; most common drug for T2D treatment
Inhibits enzymes related to gluconeogenesis and lipogenesis, results in weight loss
COMBINATION

Enables sustained reductions in HbAlc, FPG and weight without increasing the risk of hypoglycemia in patients with type 2 diabetes
Statistically superior to monotherapy in reduction of FPG (fasting plasma glucose)

Sodium-glucose co-transporter(SGLT)-2 inhibitors & Biguanide combo